NDC 68071-3765-06 - Methotrexate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-3765
- Requested NDC
- 68071-3765-06
- Package NDCs from labels
- 68071-3765-9, 68071-3765-6, 68071-3765-06
- Manufacturer
- NuCare Pharmaceuticals, Inc.
- Effective date
- 2025-01-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Methotrexate - NuCare Pharmaceuticals, Inc. | NuCare Pharmaceuticals, Inc. | 2025-01-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-3765-6 | Methotrexate | 60 in 1 BOTTLE | TABLET | 60 | 2 | |
| 68071-3765-9 | Methotrexate | 90 in 1 BOTTLE | TABLET | 90 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-3765 | METHOTREXATE TABLET [NUCARE PHARMACEUTICALS, INC.] | 2 | Current NDC, 2 package rows | 20250116_2b61822e-b488-5eaf-e063-6394a90a2dcd.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methotrexate | METHOTREXATE | A-S Medication Solutions | 22e10810-16fb-4c84-bccf-972405b77ef8 | 2026-08-27 | Boxed warning, Warnings, Adverse reactions | 105585 3IG1E710ZN |
| Methotrexate | METHOTREXATE | AvKARE | 757d6cef-6696-7a1c-8074-01258aaa8bdd | 2026-07-23 | Boxed warning, Adverse reactions | 105585 3IG1E710ZN |
| Trexall | METHOTREXATE | Teva Women's Health LLC | e942f8db-510f-44d6-acb5-b822196f5e8c | 2026-06-17 | Boxed warning, Warnings, Adverse reactions | 3IG1E710ZN |
| Methotrexate | METHOTREXATE | Bryant Ranch Prepack | b6e61c50-024a-494f-b04c-100fb371a837 | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | ANDA210454 105585 3IG1E710ZN |
| Methotrexate | METHOTREXATE | Bryant Ranch Prepack | 0b54b5c4-2466-4f85-b9a0-ad93ec4a06a1 | 2026-06-05 | Boxed warning, Warnings, Adverse reactions | 105585 3IG1E710ZN |
| Methotrexate | METHOTREXATE | Teva Pharmaceuticals USA, Inc. | 9b34b1d8-d125-41a2-9f6f-3fab67b573bd | 2026-06-04 | Boxed warning, Warnings, Adverse reactions | 105585 3IG1E710ZN |
| Methotrexate | METHOTREXATE | Major Pharmaceuticals | 2a6afc4c-819d-4ba9-8040-4504519c116a | 2026-05-28 | Boxed warning, Warnings, Adverse reactions | 105585 |
| Methotrexate | METHOTREXATE | Accord Healthcare Inc. | 874c7f43-a3be-4236-89cc-24c44e3c5813 | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | 105585 3IG1E710ZN |
| METHOTREXATE | METHOTREXATE | Bryant Ranch Prepack | 4a04756f-e1c9-4d1e-b309-7be31c9176d6 | 2026-05-26 | Boxed warning, Warnings, Adverse reactions | 105585 3IG1E710ZN |
| Methotrexate Sodium | METHOTREXATE SODIUM | Elite Laboratories, Inc. | 89c05ea3-3be1-46dd-b112-29c436fd7289 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 105585 3IG1E710ZN |
| Methotrexate | METHOTREXATE SODIUM | Sun Pharmaceutical Industries, Inc. | 8f1260de-b60c-4f0e-8af6-0e957b0a281b | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 105585 3IG1E710ZN |
| Methotrexate Sodium | METHOTREXATE SODIUM | Hikma Pharmaceuticals USA Inc. | d71b1856-99d8-4a9e-9189-f87b6675f80a | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | 105585 3IG1E710ZN |
| Methotrexate | METHOTREXATE | Bryant Ranch Prepack | 4741a44f-0d0b-4380-84f6-231a8d1560fb | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | 105585 3IG1E710ZN |
| METHOTREXATE | METHOTREXATE | Alembic Pharmaceuticals Inc. | 04a95db9-a124-4b97-bd71-1c37a6b3b0c8 | 2026-05-18 | Boxed warning, Warnings, Adverse reactions | 105585 3IG1E710ZN |
| Methotrexate | METHOTREXATE | Zydus Pharmaceuticals USA Inc. | 948e0bab-6524-4b87-9853-1799d4415558 | 2026-05-09 | Boxed warning, Warnings, Adverse reactions | 105585 |
| Methotrexate | METHOTREXATE | Mylan Pharmaceuticals Inc. | 70c09984-2b36-424f-8b27-3fd0cd4e833d | 2026-05-07 | Boxed warning, Warnings, Adverse reactions | 105585 3IG1E710ZN |
| Methotrexate | METHOTREXATE | Aurobindo Pharma Limited | 09931d44-a3f8-49dc-a3f2-b527ee4214bf | 2026-05-07 | Boxed warning, Warnings, Adverse reactions | ANDA210454 59651-182 105585 9fe03573-fff3-4051-8598-8542eee1273f 09931d44-a3f8-49dc-a3f2-b527ee4214bf 3IG1E710ZN |
| Methotrexate | METHOTREXATE | NuCare Pharmaceuticals, Inc. | 50b2cfc7-dfe4-4406-e063-6294a90a2527 | 2026-04-30 | Boxed warning, Warnings, Adverse reactions | 105585 3IG1E710ZN |
| Caldesene Baby | STARCH, CORN AND ZINC OXIDE | Insight Pharmaceuticals LLC | 9f12dee2-7afa-45e9-a729-0fd42bb77715 | 2026-04-22 | Warnings | O8232NY3SJ |
| Caldesene Medicated Protecting | CORNSTARCH AND ZINC OXIDE | Insight Pharmaceuticals LLC | ffc92a0f-a7cf-4a46-b2f1-089df2bbb96b | 2026-04-22 | Warnings | O8232NY3SJ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.